Among patients with diabetes receiving PCI, novel antidiabetic agents, compared with standard treatment, may reduce risk for acute kidney injury.

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

The makers of Wegovy and Zepbound are cutting prices to make the medications more affordable for people without insurance.

Patients with chronic kidney disease and heart failure have higher rates of inpatient dialysis initiation than those without heart failure.

Time in range was similar among pediatric patients with type 1 diabetes who used either the Insulet Omnipod 5 or the Tandem Control IQ.

The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Individual- and neighborhood-level factors affect suboptimal CVH in early pregnancy related to racial and ethnic differences.

The FDA has accepted for Priority Review the sNDA for finerenone for heart failure with mildly reduced or preserved ejection fraction.

Doctors at Duke Health have successfully performed the world’s first living mitral valve replacement, saving three lives in North Carolina.

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

The FDA has removed the risk evaluation and mitigation strategies (REMS) program requirement for Tryvio (aprocitentan).

A study has found that, in the United States, hypertension control rates vary by race, ethnicity, and geography among veterans.